ChiCTR2400089344 版本V1.0 版本创建时间2024/09/06 09:36:30 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400089344 

最近更新日期:

Date of Last Refreshed on:

2024-09-06 09:36:12 

注册时间:

Date of Registration:

2024-09-06 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

妊娠期女性DASH膳食模式与非稳态负荷的纵向研究

Public title:

Longitudinal study on dietary patterns of DASH and allostatic load in pregnant women

注册题目简写:

English Acronym:

研究课题的正式科学名称:

妊娠期女性DASH膳食模式与非稳态负荷的纵向研究

Scientific title:

Longitudinal study on dietary patterns of DASH and allostatic load in pregnant women

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李文娟 

研究负责人:

李玉红 

Applicant:

Wenjuan Li 

Study leader:

Yuhong Li 

申请注册联系人电话:

Applicant telephone:

+86 182 5690 8907

研究负责人电话:

Study leader's
telephone:

+86 138 5518 9168

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2722150554@qq.com

研究负责人电子邮件:

Study leader's E-mail:

liyuhong@ahmu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

安徽省合肥市蜀山区梅山路81号

研究负责人通讯地址:

安徽省合肥市蜀山区梅山路81号

Applicant address:

81 Meishan Road, Shushan District, Hefei City, Anhui Province.

Study leader's address:

81 Meishan Road, Shushan District, Hefei City, Anhui Province.

申请注册联系人邮政编码:

Applicant postcode:

230032

研究负责人邮政编码:

Study leader's postcode:

230032

申请人所在单位:

安徽医科大学护理学院

Applicant's institution:

School of Nursing, Anhui Medical University.

研究负责人所在单位:

安徽医科大学护理学院

Affiliation of the Leader:

School of Nursing, Anhui Medical University.

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

83242384

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

安徽医科大学生物医学伦理委员会

Name of the ethic committee:

Biomedical Ethics Committee of Anhui Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-01-01 00:00:00

伦理委员会联系人:

史琳

Contact Name of the ethic committee:

Lin Shi

伦理委员会联系地址:

安徽省合肥市蜀山区梅山路81号

Contact Address of the ethic committee:

81 Meishan Road, Shushan District, Hefei City, Anhui Province.

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 551 6516 7731

伦理委员会联系人邮箱:

Contact email of the ethic committee:

1773023592@qq.com

研究实施负责(组长)单位:

安徽医科大学

Primary sponsor:

Anhui Medical University

研究实施负责(组长)单位地址:

安徽省合肥市梅山路81号

Primary sponsor's address:

81 Meishan Road, Hefei, Anhui

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

安徽

市(区县):

合肥

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

安徽医科大学

具体地址:

安徽省合肥市蜀山区梅山路81号

Institution
hospital:

Anhui Medical University

Address:

81 Meishan Road, Hefei, Anhui

经费或物资来源:

Source(s) of funding:

None

研究疾病:

不良健康结局  

Target disease:

Adverse health outcomes

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究拟通过问卷调查、生物学指标检查,了解妊娠中、晚期女性的DASH饮食评分与AL水平,探讨妊娠中、晚期女性DASH饮食评分水平对AL的影响。  

Objectives of Study:

This study aims to investigate the dietary DASH score and AL level in women in the second and third trimesters of pregnancy through questionnaire survey and biological index examination, and to explore the effect of DASH score on AL in women in the second and third trimesters of pregnancy.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)年龄≥20 周岁; (2)自然受孕,单胎; (3)认知正常,能独立填写问卷; (4)知情同意并自愿参与本研究。

Inclusion criteria

(1) age ≥20 years old; (2) natural conception, singleton; (3) normal cognition and ability to fill out questionnaires independently; (4) Informed consent and voluntary participation in this study.

排除标准:

(1)妊娠前有基础性疾病(高血压、糖尿病等); (2)既往有严重精神病史、诊断有重度抑郁需经临床治疗者; (3)双胎、多胎、新生儿有出生缺陷者。

Exclusion criteria:

(1) patients with underlying diseases (hypertension, diabetes, etc.) before pregnancy; (2) patients with a history of severe mental illness or severe depression requiring clinical treatment; (3) twins, multiple pregnancies and newborns with birth defects.

研究实施时间:

Study execute time:

From 2024-01-01 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-03-05 00:00:00 To 2024-12-31 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

147

Group:

Observational group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

安徽 

市(区县):

合肥 

Country:

China

Province:

Anhui

City:

Hefei

单位(医院):

中国人民解放军联勤保障部队第九〇一医院  

单位级别:

三级甲等  

Institution
hospital:

The 901st Hospital of the Chinese People's Liberation Army Joint Logistic Support Force.

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

高密度脂蛋白

指标类型:

主要指标

Outcome:

high-density lipoprotein

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

血液标本

Measure time point of outcome:

second trimester, third trimester

Measure method:

blood sample

指标中文名:

总胆固醇

指标类型:

主要指标

Outcome:

total cholesterol

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

血液标本

Measure time point of outcome:

second trimester, third trimester

Measure method:

blood sample

指标中文名:

C反应蛋白

指标类型:

主要指标

Outcome:

C-reactive protein

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

血液标本

Measure time point of outcome:

second trimester, third trimester

Measure method:

blood sample

指标中文名:

血糖

指标类型:

主要指标

Outcome:

blood glucose

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

血液标本

Measure time point of outcome:

second trimester, third trimester

Measure method:

blood sample

指标中文名:

腰围

指标类型:

主要指标

Outcome:

waistline

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

体格检查

Measure time point of outcome:

second trimester, third trimester

Measure method:

physical examination

指标中文名:

臀围

指标类型:

主要指标

Outcome:

hipline

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

体格检查

Measure time point of outcome:

second trimester, third trimester

Measure method:

physical examination

指标中文名:

收缩压

指标类型:

主要指标

Outcome:

systolic pressure

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

体格检查

Measure time point of outcome:

second trimester, third trimester

Measure method:

physical examination

指标中文名:

舒张压

指标类型:

主要指标

Outcome:

diastolic pressure

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

体格检查

Measure time point of outcome:

second trimester, third trimester

Measure method:

physical examination

指标中文名:

甘油三酯

指标类型:

主要指标

Outcome:

triglyceride

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

血液标本

Measure time point of outcome:

second trimester, third trimester

Measure method:

blood sample

指标中文名:

体力活动

指标类型:

次要指标

Outcome:

physical activity

Type:

Secondary indicator

测量时间点:

孕中期、孕晚期

测量方法:

问卷调查法

Measure time point of outcome:

second trimester, third trimester

Measure method:

Questionnaire Survey

指标中文名:

抑郁

指标类型:

次要指标

Outcome:

Depression

Type:

Secondary indicator

测量时间点:

孕中期、孕晚期

测量方法:

问卷调查法

Measure time point of outcome:

second trimester, third trimester

Measure method:

Questionnaire Survey

指标中文名:

饮食

指标类型:

主要指标

Outcome:

diet

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

问卷调查

Measure time point of outcome:

second trimester, third trimester

Measure method:

questionnaire investigation

指标中文名:

体质指数

指标类型:

主要指标

Outcome:

BMI

Type:

Primary indicator

测量时间点:

孕中期、孕晚期

测量方法:

体格检查

Measure time point of outcome:

second trimester, third trimester

Measure method:

physical examination

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 20 years
最大 Max age 50 years

性别:

女性

Gender:

Female

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

原始数据拟上传到临床研究电子管理公共平台:http://www.medresman.org.cn/login.aspx;原始数据暂不公开。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Original data uploaded to the clinical research electronic management public platform: http://www.medresman.org.cn/login.aspx. The original data is not publicly available.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

孕中期、孕晚期的纸质版问卷、孕期的实验室检查结果、从保健手册或医疗记录中获得的孕妇一般情况或饮食情况,由项目组研究者通过问卷星录入后,使用Excel核对;孕中期和孕晚期使用问卷星进行问卷调查,通过Excel将明显错误以及不符合逻辑的调查结果删除。数据的录入和核对由两名不同的研究者进行。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The paper questionnaires in the second and third trimesters of pregnancy, laboratory test results during pregnancy, and general or dietary information of pregnant women obtained from health manuals or medical records were entered by the project team researchers through the questionnaire Star and checked by Excel. The questionnaire star was used to conduct the questionnaire survey in the second and third trimester of pregnancy, and the obvious errors and unreasonable survey results were deleted by Excel. Data entry and checking were performed by two different investigators.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2024-09-06 09:36:12